FindTrial
Sign In

To study the antibiotic use in children admitted to Intensive Care Unit

A prospective antibacterial utilization study in Pediatric Intensive Care Unit of a tertiary referral center - -

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/01/007718
Enrollment
200
Registered
2017-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Admitted to Pediatric Intensive Care Unit

Interventions

None listed

Sponsors

Dept of Clinical Pharmacology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients newly admitted to pediatric intensive care of hospital and Willingness of legally acceptable representative of patient to give written informed consent

Exclusion criteria

Exclusion criteria: Patents admitted before the initiation of study were not included

Design outcomes

Primary

MeasureTime frame
Proportion of patients receiving either vancomycin or colistin or meropenem or imipenem or piperacillin-tazobactum or in combination with each otherTimepoint: From day 1 of admission till discharge, transfer or death—

Secondary

MeasureTime frame
To assess the proportion of antibacterials prescribed on the basis of culture and sensitivity report and to calculate the cost of antibacterial drug treatmentTimepoint: From day 1 of admission till discharge, transfer or death—

Countries

India

Contacts

Public ContactNitin Mali

Seth GS Medical College and KEM Hospital

nitinbmali85@gmail.com02224133767

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026